Heart drug developer Kardigan Inc. priced its IPO shares at $16 — bringing in $400 million — ahead of open-market sales of ...
If you enjoy solving puzzles, working in fast-paced environments, and protecting people and organizations from digital harm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results